Targeting KRAS: Good, But Is It Good Enough?

Author:
Margaret Tempero
Search for other papers by Margaret Tempero in
Current site
Google Scholar
PubMed Close
 MD
Volume/Issue:
Volume 19: Issue 9
Online Publication Date:
20 Sep 2021
DOI:
https://doi.org/10.6004/jnccn.2021.0044
Restricted access
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Skoulidis F, Li BT, Dy GK, et al. Sotorasib for lung cancers with KRAS p.G12C mutation. N Engl J Med 2021;384:2371–2381.

  • 2.

    Hong DS, Fakih MG, Strickler JH, et al. KRASG12C inhibition with sotorasib in advanced solid tumors. N Engl J Med 2020;383:1207–1217.

Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
1
Article Category:
Research Article
Print Publication Date:
01 Sep 2021
Online Publication Date:
20 Sep 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2548 209 19
PDF Downloads 1289 40 6
EPUB Downloads 0 0 0